application:It is a nootropic drug.
description:Coluracetam (BCI-540) is a nootropic drug of the racetam family.Coluracetam (formerly known as MKC-231) was initially developed and tested by the Mitsubishi Tanabe Pharma Corporation for Alzheimer's disease. After the drug failed to reach endpoints in its clinical trials it was in-licensed by BrainCells Inc for investigations into major depression disorder (MDD), after being awarded a "Qualifying Therapeutic Discovery Program Grant" by the state of California.Findings from its Phase 2a clinical trials have suggested that it would be an ideal medication for co-morbid MDD with generalized anxiety disorder (GAD). BrainCells Inc is currently out-licensing the drug for this purpose.It may also have potential use in prevention and treatment of ischemic retinopathy and retinal and optic nerve injury.
Please at any time if you are interested in Coluracetam.
If you want to know about Coluracetam price , please call our Customer Services Hotline +86 592 5365887 or send the email to email@example.com.
Tel: +86 592 5365887
WhatsApp: +86 189 6515 7632
Leave a Message
We will contact you within 24 hours.